Comparison · NCT02284191-cacebb3d
CT Coronary Angiogram vs Standard Care: Coronary Heart Disease (CHD) Death or Subsequent Non-fatal MI (Type 1 or 4b)
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. CT Coronary Angiogram vs Standard Care: Coronary Heart Disease (CHD) Death or Subsequent Non-fatal MI (Type 1 or 4b). Trial comparisons, record NCT02284191-cacebb3d. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02284191-cacebb3d
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.049 | 0.0366 | 0.0654 | wilson | |
| Risk in group 2 | 0.0494 | 0.0369 | 0.0658 | wilson | |
| Risk difference, group 1 minus group 2 | -0.000338 | -0.021 | 0.0203 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.993 | 0.658 | 1.5 | log | |
| Odds ratio, group 1 over group 2 | 0.993 | 0.644 | 1.53 | log | |
| Number needed to treat, for one fewer participant with the outcome on CT Coronary Angiogram than on Standard Care | 2,960 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: standard care.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | CT Coronary Angiogram | CT Coronary Angiogram plus standard care~CT Coronary Angiogram: Completion of a CT Coronary Angiogram | 43 | 877 | OG000 |
| Group 2 | Standard Care | Standard care only | 43 | 871 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Coronary Heart Disease (CHD) Death or Subsequent Non-fatal MI (Type 1 or 4b)
- Description
- Number of participants with Coronary heart disease death or subsequent non-fatal myocardial infarction (type 1 or 4b), one year after randomisation
- Time frame
- 1 year (post randomisation)
- Population
Source ClinicalTrials.gov
Trial
- Title
- Rapid Assessment of Potential Ischaemic Heart Disease With CTCA
- NCT number
- NCT02284191
- Phases
- NA
- Conditions
- Acute Coronary Syndrome
- Interventions
- CT Coronary Angiogram
- Lead sponsor
- University of Edinburgh
- Results first posted
- 2024-08-21
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02284191?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02284191-cacebb3d